Tagged with Everest Medicines

China Pharma News: Paxlovid’s Exclusion from National Insurance; CanSino’s mRNA Booster Trial; WuXi/GSK T-cell Deal; Biocytogen/Hansoh Antibody Collab
China Pharma News: AstraZeneca’s respiratory plans, Gilead’s USD 455 deal with Everest Medicines, Sanofi’s partnership with Innovent …
2020’s Top 7 Biotech IPOs in Profile
Chinese Biotech Strategies: The Pros & Cons of In-Licensing
Kerry Blanchard – CEO, Everest Medicines, China
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here